Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study
Yong Yang Yuan Zhu Jian-Zhong Cao Yu-Jing Zhang Li-Ming Xu Zhi-Yong Yuan Jun-Xin Wu Wei Waneg Tao Wu Bing Lu Su-Yu Zhu Li-Ting Qian Fu-Quan Zhang Xiao-Rong Hou Ye-Xiong Li
Cancer Hospital and Institute, Peking Union Medical College (PUMC) and Chinese Academy of Medical Sc Zhejiang Cancer Hospital, Hangzhou, Zhejiang, P.R.China Shanxi Cancer Hospital, Taiyuan, Shanxi, P.R.China Sun Yat-sen University Cancer Center,Guangzhou, Guangdong, P.R.China Cancer Hospital, Tianjin Medical University, Tianjin, P.R.China Fujian Provincial Cancer Hospital, Fuzhou, Fujian,P.R.China Guizhou Cancer Hospital, Guiyang, Guizhou, P.R.China Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, Hu The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui, P.R.China Peking Union Medical College Hospital, CAMS and PUMC, Beijing, P.R.China
国内会议
北京
英文
326-334
2016-01-09(万方平台首次上网日期,不代表论文的发表时间)